Biostem Technologies Inc
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wou… Read more
Biostem Technologies Inc (BSEM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: 0.200x
Based on the latest financial reports, Biostem Technologies Inc (BSEM) has a cash flow conversion efficiency ratio of 0.200x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($8.16 Million) by net assets ($40.88 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Biostem Technologies Inc - Cash Flow Conversion Efficiency Trend (1999–2024)
This chart illustrates how Biostem Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Biostem Technologies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biostem Technologies Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Life & Banc Split Corp
TO:LBS
|
-0.001x |
|
TAKYX
NMFQS:TAKYX
|
N/A |
|
HARMONIC (HMC.SG)
STU:HMC
|
0.020x |
|
KEPPEL (KEP1.SG)
STU:KEP1
|
-0.047x |
|
BIYT39
SA:BIYT39
|
N/A |
|
Millennium Food-Tech LP
TA:MIFT
|
N/A |
|
PARROT (P2W.SG)
STU:P2W
|
N/A |
|
Applied Nutrition Plc
LSE:APN
|
0.160x |
Annual Cash Flow Conversion Efficiency for Biostem Technologies Inc (1999–2024)
The table below shows the annual cash flow conversion efficiency of Biostem Technologies Inc from 1999 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $40.88 Million | $24.48 Million | 0.599x | -83.17% |
| 2023-12-31 | $-983.67K | $-3.50 Million | 3.557x | +758.31% |
| 2022-12-31 | $-3.95 Million | $-1.64 Million | 0.414x | +2094.10% |
| 2021-12-31 | $-5.79 Million | $-109.44K | 0.019x | -81.71% |
| 2020-12-31 | $-5.63 Million | $-581.57K | 0.103x | -51.95% |
| 2019-12-31 | $-3.94 Million | $-845.79K | 0.215x | -90.18% |
| 2018-12-31 | $-1.67 Million | $-3.66 Million | 2.189x | +294.56% |
| 2017-12-31 | $1.46 Million | $-1.65 Million | -1.125x | +68.05% |
| 2016-12-31 | $481.08K | $-1.69 Million | -3.522x | -1538.00% |
| 2015-12-31 | $1.64 Million | $-353.58K | -0.215x | +56.67% |
| 2014-12-31 | $373.83K | $-185.49K | -0.496x | -133.53% |
| 1999-12-31 | $-1.89 Million | $-2.80 Million | 1.480x | -- |